Caricamento...

A New Mechanism of Action in Heart Failure: Angiotensin-Receptor Neprilysin Inhibition

Objective: To evaluate the efficacy, safety, and clinical significance of sacubitril/valsartan (Entresto) in patients with heart failure with a reduced ejection fraction (HFrEF). Data Sources: An extensive search was conducted on Ovid MEDLINE using keywords and medical subject headings LCZ696, sacub...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Pharm Technol
Autori principali: Richardson, Jonathan, David, Tosin, Grace, Yasmin, Guirguis, Erenie
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2015
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5998462/
https://ncbi.nlm.nih.gov/pubmed/34860952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122515622224
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !